N-甲基-N-(1-羰基十八烷基)氨基乙酸铵 | 108646-71-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: N-甲基-N-(1-羰基十八烷基)氨基乙酸铵
• 英文名称: N-Acetyl-DL-β-methionin-sulfoxid
• 英文别名: Acetyl-methionin-sulfoxid；N-Acetylmethionine sulfoxide；2-acetamido-4-methylsulfinylbutanoic acid
• CAS: 108646-71-5；114714-85-1；3054-51-1
• 化学式: C₇H₁₃NO₄S
• mdl: MFCD24391014
• 分子量: 207.251
• InChiKey: NPIMMZJBURSMON-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.4
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.714
• 拓扑面积：
  103
• 氢给体数：
  2
• 氢受体数：
  5

安全信息

• 海关编码：
  2930909090
• 储存条件：
  存于室温下，请密封并保持干燥。

反应信息

• 作为产物：
  描述：

  N-乙酰-DL-蛋氨酸 在 氧气 作用下， 以 甲醇 为溶剂， 20.0 ℃ 、100.0 kPa 条件下， 以99%的产率得到N-甲基-N-(1-羰基十八烷基)氨基乙酸铵
  参考文献：
  名称：

  Mixed-ligand metal–organic frameworks as an effective photocatalyst for selective oxidation reaction

  摘要：

  混合配体 Zn-MIX 可用于胺和硫化物的光氧化，这为设计具有相当光催化活性的多组分 MOFs 提供了一种有前途的策略。

  DOI：

  10.1039/d3cc02839a

文献信息

• Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
  申请人：DermBiont, Inc.

  公开号：US11040077B2

  公开（公告）日：2021-06-22

  Disclosed herein are compositions and methods for using human-derived Janthinobacterium lividum. Compositions improve skin health. Methods may include applying human-derived Janthinobacterium lividum over a host or host area, such as skin or mucosa, to minimize the presence of one or more microbes, maximize therapeutic effects, and/or improve health. A method to minimize a pathogenic microbe may include applying to a surface a composition including human-derived Janthinobacterium lividum and an acceptable carrier. Compositions and methods may include a prebiotic to maximize growth and/or metabolites. Compositions and methods may include human-derived Janthinobacterium lividum metabolites, such as violacein, prodigiosin, indole-3-carboxaldehyde, and lantibiotics, and/or other Postbiotics.

  本文公开了使用源自人类的 Lividum Janthinobacterium 的组合物和方法。组合物可改善皮肤健康。方法可包括在宿主或宿主区域（如皮肤或粘膜）上施用源于人的生发的Lividum Janthinobacterium，以最大限度地减少一种或多种微生物的存在，最大限度地提高治疗效果，和/或改善健康状况。减少病原微生物的方法可包括向表面施用一种组合物，该组合物包括来源于人类的Janthinobacterium lividum和一种可接受的载体。组合物和方法可包括益生元，以最大限度地提高生长和/或代谢物。组合物和方法可包括来源于人的猪蓝细菌代谢物，如violacein、prodigiosin、吲哚-3-甲醛、兰特益生菌和/或其他后益生菌。
• Selective Aerobic Oxidation of Sulfides Using a Novel Palladium Complex as the Catalyst Precursor
  作者：Raluca Aldea、Howard Alper

  DOI：10.1021/jo00131a009

  日期：1995.12

  The palladium complex [Pd(PBu(2)(t)H)(mu-PBu(2)(t))](2), on exposure to oxygen in THF, generates an active catalytic system for the selective oxidation of sulfides to sulfoxides in 30-83% yields. The process is stereospecific in the case of (+)-biotin-sulfoxide 4-nitrophenyl ester.
• ASPARAGINE SYNTHETASE INHIBITORS AND USES THEREOF
  申请人：Ospedale San Raffaele S.r.l.

  公开号：EP3847257A1

  公开（公告）日：2021-07-14
• FECAL-DERIVED STERILE POSTBIOTIC COMPOSITION AND METHOD THEREFOR
  申请人：Thaena Inc.

  公开号：EP4045069A1

  公开（公告）日：2022-08-24
• COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES
  申请人：DermBiont, Inc.

  公开号：US20200345799A1

  公开（公告）日：2020-11-05

  Disclosed herein are compositions and methods for using human-derived Janthinobacterium lividum . Compositions improve skin health. Methods may include applying human-derived Janthinobacterium lividum over a host or host area, such as skin or mucosa, to minimize the presence of one or more microbes, maximize therapeutic effects, and/or improve health. A method to minimize a pathogenic microbe may include applying to a surface a composition including human-derived Janthinobacterium lividum and an acceptable carrier. Compositions and methods may include a prebiotic to maximize growth and/or metabolites. Compositions and methods may include human-derived Janthinobacterium lividum metabolites, such as violacein, prodigiosin, indole-3-carboxaldehyde, and lantibiotics, and/or other Postbiotics.